Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Scleroderma 2016 RMAP 4DP2OD008752-02 Investigation and Development of New Therapeutic Avenues for Scleroderma MAVERAKIS, EMANUAL UNIVERSITY OF CALIFORNIA AT DAVIS CA $510,250
Scleroderma 2016 NHLBI 5U01HL125175-02 Hopkins Clinical Center for Pulmonary Vascular Disease Phenomics Program HASSOUN, PAUL JOHNS HOPKINS UNIVERSITY MD $157,394
Scleroderma 2016 NHLBI 5K23HL119623-02 Early Detection of Scleroderma-Associated Pulmonary Arterial Hypertension VISOVATTI, SCOTT UNIVERSITY OF MICHIGAN MI $193,319
Scleroderma 2016 NIAMS 4K24AR060297-05 Scleroderma Twin Study FEGHALI-BOSTWICK, CAROL MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $129,866
Scleroderma 2016 NIAMS 5R03AR066343-02 Adipokine Modulation of Fibrosis: Novel Scleroderma Pathway GONCALVES MARANGONI, ROBERTA NORTHWESTERN UNIVERSITY AT CHICAGO IL $69,525
Scleroderma 2016 NIAMS 5R21AR066305-02 Effect of Atorvastatin on Endothelial Function and Raynaud in Diffuse Scleroderma DOMSIC, ROBYN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $168,655
Scleroderma 2016 NIAMS 5R01AR056672-07 The Pharmacology of Dermal Fibrosis CRONSTEIN, BRUCE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $372,900
Scleroderma 2016 NHLBI 5R01HL126897-02 The Mechanisms of Profibrotic Sensitization by IL33 ATAMAS, SERGEI UNIVERSITY OF MARYLAND BALTIMORE MD $345,375
Scleroderma 2016 NIAMS 5R21AR068035-02 Molecular Biomarkers of Improvement for Patients with Systemic Sclerosis in an Open Label Trial of Mycophenolate Mofetil WHITFIELD, MICHAEL DARTMOUTH COLLEGE NH $174,900
Scleroderma 2016 NIAMS 1K23AR067889-01A1 Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment FRECH, TRACY UNIVERSITY OF UTAH UT $175,932
Scleroderma 2016 NIAID 5UM1AI110557-03 University of Michigan Autoimmunity Center of Excellence, Clinical Research Progr FOX, DAVID UNIVERSITY OF MICHIGAN MI $77,500
Scleroderma 2016 NIAMS 1R03AR068097-01A1 Regulation of Macrophage Activation and Inflammation in Scleroderma PIOLI, PATRICIA DARTMOUTH COLLEGE NH $81,000
Scleroderma 2016 NIAMS 4K08AR062592-05 The Role Of Lysophosphatidic Acid (LPA) And Its Receptor, LPA1 In Scleroderma CASTELINO, FLAVIA MASSACHUSETTS GENERAL HOSPITAL MA $162,854
Scleroderma 2016 NCCIH 1R43AT008634-01A1 Transcutaneous Neuromodulation at Acupoint for Gastric Complications of Scleroderma YIN, JIEYUN TRANSTIMULATION RESEARCH, INC. OK $265,665
Scleroderma 2016 NIAMS 5R03AR065801-03 DNA methylation biomarkers of scleroderma-associated interstitial lung disease RAMOS, PAULA MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $81,467
Scleroderma 2016 NHLBI 4K01HL118712-04 Mechanisms of Increased Lung Fibrosis in Males VALERA, ISELA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $118,360
Scleroderma 2016 NHLBI 5R34HL122558-02 Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis JAIN, MANU NORTHWESTERN UNIVERSITY AT CHICAGO IL $214,205
Scleroderma 2016 NIAMS 5R01AR066049-03 Inhibition of the Rho/MRTF/SRF Pathway as a New Treatment for Systemic Sclerosis LARSEN, SCOTT UNIVERSITY OF MICHIGAN MI $631,620
Scleroderma 2016 NIAMS 5R01AR042334-22 The molecular mechanism of vasculopathy and fibrosis in scleroderma TROJANOWSKA, MARIA BOSTON UNIVERSITY MEDICAL CAMPUS MA $360,140
Scleroderma 2016 NHLBI 4R01HL114910-05 Mechanisms of Right Ventricular Dysfunction in PAH HASSOUN, PAUL JOHNS HOPKINS UNIVERSITY MD $633,919
Scleroderma 2016 NHLBI 5R01HL115813-03 Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung Disease LEE, CHUN GEUN BROWN UNIVERSITY RI $358,644
Scleroderma 2016 NIAMS 5K08AR065507-03 TSLP profibrotic signaling and its interaction with TGF-beta CHRISTMANN, ROMY BOSTON UNIVERSITY MEDICAL CAMPUS MA $108,588
Scleroderma 2016 NHLBI 5R01HL124213-02 Non-Visual Opsins & Vasoregulation: Implications for Vascular Therapy BERKOWITZ, DAN JOHNS HOPKINS UNIVERSITY MD $400,401
Scleroderma 2016 NIAMS 1R01AR068317-01A1 Genomics of Variability in Progression and Severity of Skin Fibrosis YATES, CECELIA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $337,526
Scleroderma 2016 NHLBI 1R01HL125850-01A1 Neuroimmune Molecules in Scleroderma Lung Fibrosis HERZOG, ERICA YALE UNIVERSITY CT $434,436
Scleroderma 2016 NIAMS 5R03AR065800-03 Synthetic Oleananes: Innovative Treatment of Fibrosis BHATTACHARYYA, SWATI NORTHWESTERN UNIVERSITY AT CHICAGO IL $77,250
Scleroderma 2016 NIAMS 4P60AR047785-15 6147 Methodology Core ZHANG, YUQING BOSTON UNIVERSITY MEDICAL CAMPUS MA $703,487
Scleroderma 2016 NIAMS 4K23AR061439-05 Cancer, Autoantigens, and Scleroderma Investigating the Connection SHAH, AMI JOHNS HOPKINS UNIVERSITY MD $151,711
Scleroderma 2016 NIAMS 4R01AR062078-05 Caveolin-1 Regulates Monocyte-Fibrocyte Lineage Cell Functions via CXCR4 TOURKINA, ELENA MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $331,875
Scleroderma 2016 NIAMS 4P60AR064464-04 6313 Methodology Core CHANG, ROWLAND NORTHWESTERN UNIVERSITY AT CHICAGO IL $498,825
Scleroderma 2016 NHLBI 4R01HL114887-05 Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar STENMARK, KURT UNIVERSITY OF COLORADO DENVER CO $687,714
Scleroderma 2016 NIAMS 5R03AR065755-03 Pathogenesis of systemic sclerosis: role of the skin-resident CD8+ T cells FUSCHIOTTI, PATRIZIA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $77,000
Scleroderma 2016 NHLBI 4R42HL127802-02 Peptide Based Therapy for Lung Fibrosis PADGETT, HAL NOVICI BIOTECH, LLC CA $749,790
Scleroderma 2016 NIAMS 5R21AR065089-02 Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma SILVER, RICHARD MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $151,365
Scleroderma 2016 NIAMS 4K24AR063120-05 Outcomes Research in Rheumatic Diseases KHANNA, DINESH UNIVERSITY OF MICHIGAN MI $179,586
Scleroderma 2016 NIAMS 4P60AR062755-05 6266 Patient Resource Core SMITH, EDWIN MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $303,617
Scleroderma 2016 NIAMS 4P60AR062755-05 6267 Defective c-MET signaling in African American scleroderma patients SILVER, RICHARD MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $316,194
Scleroderma 2016 NIAMS 4R01AR062056-06 Cadherin-11 Regulation Of Dermal Fribrosis And Macrophage Function AGARWAL, SANDEEP BAYLOR COLLEGE OF MEDICINE TX $351,310
Scleroderma 2016 NHLBI 4UH3HL123827-03 Targeting resitin and RELM-beta to treat pulmonary hypertension JOHNS, ROGER JOHNS HOPKINS UNIVERSITY MD $1,620,550
Scleroderma 2016 NIAMS 1K08AR070285-01 Contribution of Adipocytes and Adipose Secreted Factors to Fibrosis in Systemic Sclerosis KORMAN, BENJAMIN NORTHWESTERN UNIVERSITY AT CHICAGO IL $157,245
Scleroderma 2016 NIAMS 1R01AR068379-01A1 Mechanistic and Therapeutic Investigations of Scleroderma DIETZ, HARRY JOHNS HOPKINS UNIVERSITY MD $358,600
Scleroderma 2016 NIAMS 1R21AR069822-01A1 Role of PTP4A1 in systemic sclerosis BOTTINI, NUNZIO UNIVERSITY OF CALIFORNIA SAN DIEGO CA $170,500
Scleroderma 2016 NIGMS 1R41GM121174-01 DRUG DISCOVERY PLATFORM FOR PROTEIN ARGININE METHYLTRANSFERASE INHIBITORS ALETTA, JOHN CH3 BIOSYSTEMS, LLC NY $157,500
Scleroderma 2016 NIAID 272201100025C-11-0-1 SCLERODERMA CYCLOPHOSPHAMIDE OR TRANSPLANTION STUDY (SCOT) SULLIVAN, KEITH DUKE UNIVERSITY NC $663,219
Scleroderma 2016 NHLBI 5F32HL129687-02 Detection of Early Pulmonary Vascular Disease in Scleroderma MULLIN, CHRISTOPHER JOHNS HOPKINS UNIVERSITY MD $66,354
Scleroderma 2016 NIDCR 1K99DE025915-01A1 FAS Controls Exosome-Mediated miRNA Transfer in MSC-Based Therapy CHEN, CHI-DER UNIVERSITY OF PENNSYLVANIA PA $70,779
Scleroderma 2016 NIAMS 3R01AR056672-07S1 The Pharmacology of Dermal Fibrosis CRONSTEIN, BRUCE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $62,323
Scleroderma 2016 NIAMS 5R01AR066676-03 HTS for selective inhibitors of Meprin alpha and beta MINOND, DMITRIY AUBURN UNIVERSITY AT AUBURN AL $364,505
Scleroderma 2016 NIA 1R56AG054207-01 Sirtuins: novel determinants and therapeutic target in systemic sclerosis VARGA, JOHN NORTHWESTERN UNIVERSITY AT CHICAGO IL $519,580
Scleroderma 2016 NIAMS 1ZIEAR041176-09 Clinical Training in Rheumatology SIEGEL, RICHARD NIH $1,697,705
Scleroderma 2016 NHGRI 1ZIAHG200371-06 Genetic Analysis of Complex Inflammatory Disorders KASTNER, DANIEL NIH $1,308,268


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer